Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiral S Gangadin

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|July 24, 2019
The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic ReviewAlbert Batalla, Hella Janssen, Shiral S Gangadin, et al.
JAMA Psychiatry|January 28, 2026
Interpretation of the HAMLETT Study-ReplyIris E Sommer, Shiral S Gangadin, Franciska de Beer
Schizophrenia Bulletin|June 14, 2026
Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode PsychosisShiral S Gangadin, Franciska de Beer, Iris E Sommer
Current Opinion in Psychiatry|March 29, 2019
MRI investigation of immune dysregulation in schizophreniaShiral S Gangadin, Lyliana G Nasib, Iris E C Sommer, et al.
Journal of Psychiatric Research|April 9, 2021
Reduced resting state functional connectivity in the hippocampus-midbrain-striatum network of schizophrenia patientsShiral S Gangadin, Wiepke Cahn, Thomas W Scheewe, et al.
The American Journal of Psychiatry|September 12, 2024
Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective DisorderBodyl A Brand, Iris E Sommer, Shiral S Gangadin, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 4, 2024
[Antipsychotic medication after a first episode of psychosis: taper or continue?]Lieuwe de Haan, Shiral S Gangadin, Franciska de Beer, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 28, 2026
Citalopram serum concentrations in men and women of pre- and post-menopausal ageEline L Bosch, Franciska de Beer, Danielle C Cath, et al.
Brain and Behavior|April 25, 2023
Association between gut permeability, brain volume, and cognition in healthy participants and patients with schizophrenia spectrum disorderToon Anton Willem Scheurink, Jenny Borkent, Shiral S Gangadin, et al.
Schizophrenia Bulletin|March 21, 2026
The Impact of Sex and Age on Antipsychotic Serum ConcentrationsFranciska de Beer, Bodyl A Brand, Ben Wijnen, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|July 24, 2019
The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic ReviewAlbert Batalla, Hella Janssen, Shiral S Gangadin, et al.
JAMA Psychiatry|January 28, 2026
Interpretation of the HAMLETT Study-ReplyIris E Sommer, Shiral S Gangadin, Franciska de Beer
Schizophrenia Bulletin|June 14, 2026
Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode PsychosisShiral S Gangadin, Franciska de Beer, Iris E Sommer
Current Opinion in Psychiatry|March 29, 2019
MRI investigation of immune dysregulation in schizophreniaShiral S Gangadin, Lyliana G Nasib, Iris E C Sommer, et al.
Journal of Psychiatric Research|April 9, 2021
Reduced resting state functional connectivity in the hippocampus-midbrain-striatum network of schizophrenia patientsShiral S Gangadin, Wiepke Cahn, Thomas W Scheewe, et al.
The American Journal of Psychiatry|September 12, 2024
Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective DisorderBodyl A Brand, Iris E Sommer, Shiral S Gangadin, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 4, 2024
[Antipsychotic medication after a first episode of psychosis: taper or continue?]Lieuwe de Haan, Shiral S Gangadin, Franciska de Beer, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 28, 2026
Citalopram serum concentrations in men and women of pre- and post-menopausal ageEline L Bosch, Franciska de Beer, Danielle C Cath, et al.
Brain and Behavior|April 25, 2023
Association between gut permeability, brain volume, and cognition in healthy participants and patients with schizophrenia spectrum disorderToon Anton Willem Scheurink, Jenny Borkent, Shiral S Gangadin, et al.
Schizophrenia Bulletin|March 21, 2026
The Impact of Sex and Age on Antipsychotic Serum ConcentrationsFranciska de Beer, Bodyl A Brand, Ben Wijnen, et al.
Pageof 4